These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 31149037)

  • 1. High OGT activity is essential for MYC-driven proliferation of prostate cancer cells.
    Itkonen HM; Urbanucci A; Martin SE; Khan A; Mathelier A; Thiede B; Walker S; Mills IG
    Theranostics; 2019; 9(8):2183-2197. PubMed ID: 31149037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer cells.
    Itkonen HM; Minner S; Guldvik IJ; Sandmann MJ; Tsourlakis MC; Berge V; Svindland A; Schlomm T; Mills IG
    Cancer Res; 2013 Aug; 73(16):5277-87. PubMed ID: 23720054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
    Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
    Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. O-GlcNAc transferase couples MRE11 to transcriptionally active chromatin to suppress DNA damage.
    Gondane A; Girmay S; Helevä A; Pallasaho S; Loda M; Itkonen HM
    J Biomed Sci; 2022 Feb; 29(1):13. PubMed ID: 35164752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The THAP-zinc finger protein THAP1 associates with coactivator HCF-1 and O-GlcNAc transferase: a link between DYT6 and DYT3 dystonias.
    Mazars R; Gonzalez-de-Peredo A; Cayrol C; Lavigne AC; Vogel JL; Ortega N; Lacroix C; Gautier V; Huet G; Ray A; Monsarrat B; Kristie TM; Girard JP
    J Biol Chem; 2010 Apr; 285(18):13364-71. PubMed ID: 20200153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-linked N-acetylglucosamine transferase promotes cervical cancer tumorigenesis through human papillomaviruses E6 and E7 oncogenes.
    Kim M; Kim YS; Kim H; Kang MY; Park J; Lee DH; Roh GS; Kim HJ; Kang SS; Cho GJ; Park JK; Cho JW; Shin JK; Choi WS
    Oncotarget; 2016 Jul; 7(28):44596-44607. PubMed ID: 27331873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of O-GlcNAc transferase activity reprograms prostate cancer cell metabolism.
    Itkonen HM; Gorad SS; Duveau DY; Martin SE; Barkovskaya A; Bathen TF; Moestue SA; Mills IG
    Oncotarget; 2016 Mar; 7(11):12464-76. PubMed ID: 26824323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis.
    Lynch TP; Ferrer CM; Jackson SR; Shahriari KS; Vosseller K; Reginato MJ
    J Biol Chem; 2012 Mar; 287(14):11070-81. PubMed ID: 22275356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of O-Linked N-Acetylglucosamine Transferase Reduces Replication of Herpes Simplex Virus and Human Cytomegalovirus.
    Angelova M; Ortiz-Meoz RF; Walker S; Knipe DM
    J Virol; 2015 Aug; 89(16):8474-83. PubMed ID: 26041297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The conserved threonine-rich region of the HCF-1
    Kapuria V; Röhrig UF; Waridel P; Lammers F; Borodkin VS; van Aalten DMF; Zoete V; Herr W
    J Biol Chem; 2018 Nov; 293(46):17754-17768. PubMed ID: 30224358
    [No Abstract]   [Full Text] [Related]  

  • 11. Undetectable histone O-GlcNAcylation in mammalian cells.
    Gagnon J; Daou S; Zamorano N; Iannantuono NV; Hammond-Martel I; Mashtalir N; Bonneil E; Wurtele H; Thibault P; Affar el B
    Epigenetics; 2015; 10(8):677-91. PubMed ID: 26075789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear factor-erythroid-2 related transcription factor-1 (Nrf1) is regulated by O-GlcNAc transferase.
    Han JW; Valdez JL; Ho DV; Lee CS; Kim HM; Wang X; Huang L; Chan JY
    Free Radic Biol Med; 2017 Sep; 110():196-205. PubMed ID: 28625484
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Sekine H; Okazaki K; Kato K; Alam MM; Shima H; Katsuoka F; Tsujita T; Suzuki N; Kobayashi A; Igarashi K; Yamamoto M; Motohashi H
    Mol Cell Biol; 2018 Sep; 38(17):. PubMed ID: 29941490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.
    Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D
    Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parallel study on protein O-GlcNAcylation in prostate cancer cell with a sensitive microarray biochip.
    Lei L; Xie J; Yu J; Li Y; Liu Y
    Anal Biochem; 2018 Oct; 558():53-59. PubMed ID: 30086259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct OGT-Binding Sites Promote HCF-1 Cleavage.
    Bhuiyan T; Waridel P; Kapuria V; Zoete V; Herr W
    PLoS One; 2015; 10(8):e0136636. PubMed ID: 26305326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-GlcNAc transferase/host cell factor C1 complex regulates gluconeogenesis by modulating PGC-1α stability.
    Ruan HB; Han X; Li MD; Singh JP; Qian K; Azarhoush S; Zhao L; Bennett AM; Samuel VT; Wu J; Yates JR; Yang X
    Cell Metab; 2012 Aug; 16(2):226-37. PubMed ID: 22883232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS.
    Deplus R; Delatte B; Schwinn MK; Defrance M; Méndez J; Murphy N; Dawson MA; Volkmar M; Putmans P; Calonne E; Shih AH; Levine RL; Bernard O; Mercher T; Solary E; Urh M; Daniels DL; Fuks F
    EMBO J; 2013 Mar; 32(5):645-55. PubMed ID: 23353889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammalian cell proliferation requires noncatalytic functions of O-GlcNAc transferase.
    Levine ZG; Potter SC; Joiner CM; Fei GQ; Nabet B; Sonnett M; Zachara NE; Gray NS; Paulo JA; Walker S
    Proc Natl Acad Sci U S A; 2021 Jan; 118(4):. PubMed ID: 33419956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of O-GlcNAc by prostate cancer cells is significantly associated with poor prognosis of patients.
    Kamigaito T; Okaneya T; Kawakubo M; Shimojo H; Nishizawa O; Nakayama J
    Prostate Cancer Prostatic Dis; 2014 Mar; 17(1):18-22. PubMed ID: 24366413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.